Method of Treating Scoliosis Using a Biological Implant
AssigneeMichael R. Schramm
InventorsJames W. Ogilvie, Kenneth Ward, Lesa M. Nelson
Life of this patent
Estimating the term…
Loading patent…
AssigneeMichael R. Schramm
InventorsJames W. Ogilvie, Kenneth Ward, Lesa M. Nelson
Estimating the term…
The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.
A method comprising applying a genetically inherited adolescent female dominant disease therapeutic to a patient having a genetically inherited adolescent female dominant disease altered risk associated biological marker.
A method comprising applying a genetically inherited female dominant disease resistance therapeutic to a patient having a genetically inherited adolescent female dominant disease altered risk associated biological marker.
A method comprising applying at least one of a genetically inherited adolescent female dominant disease therapeutic and a genetically inherited adolescent female dominant disease resistance therapeutic to a patient having at least one genetically inherited adolescent female dominant disease altered risk associated biological marker.
Dependencies are inferred from the claim text.